• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7-氧代-二氢螺[吲唑-5,4'-哌啶]乙酰辅酶A羧化酶抑制剂的合成

Synthesis of 7-oxo-dihydrospiro[indazole-5,4'-piperidine] acetyl-CoA carboxylase inhibitors.

作者信息

Bagley Scott W, Southers James A, Cabral Shawn, Rose Colin R, Bernhardson David J, Edmonds David J, Polivkova Jana, Yang Xiaojing, Kung Daniel W, Griffith David A, Bader Scott J

机构信息

Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, USA.

出版信息

J Org Chem. 2012 Feb 3;77(3):1497-506. doi: 10.1021/jo202377g. Epub 2012 Jan 25.

DOI:10.1021/jo202377g
PMID:22239115
Abstract

Synthesis of oxo-dihydrospiroindazole-based acetyl-CoA carboxylase (ACC) inhibitors is reported. The dihydrospiroindazoles were assembled in a regioselective manner in six steps from substituted hydrazines and protected 4-formylpiperidine. Enhanced regioselectivity in the condensation between a keto enamine and substituted hydrazines was observed when using toluene as the solvent, leading to selective formation of 1-substituted spiroindazoles. The 2-substituted spiroindazoles were formed selectively from alkyl hydrazones by ring closure with Vilsmeier reagent. The key step in the elaboration to the final products is the conversion of an intermediate olefin to the desired ketone through elimination of HBr from an O-methyl bromohydrin. This methodology enabled the synthesis of each desired regioisomer on 50-75 g scale with minimal purification. Acylation of the resultant spirocyclic amines provided potent ACC inhibitors.

摘要

报道了基于氧代二氢螺吲哚并吡唑的乙酰辅酶A羧化酶(ACC)抑制剂的合成。二氢螺吲哚并吡唑由取代肼和受保护的4-甲酰基哌啶通过六步区域选择性组装而成。当使用甲苯作为溶剂时,在酮烯胺与取代肼之间的缩合反应中观察到区域选择性增强,导致选择性形成1-取代的螺吲哚并吡唑。2-取代的螺吲哚并吡唑通过与Vilsmeier试剂闭环,由烷基腙选择性形成。最终产物制备中的关键步骤是通过从O-甲基溴代醇中消除HBr,将中间体烯烃转化为所需的酮。该方法能够以50-75克规模合成每种所需的区域异构体,且纯化步骤最少。所得螺环胺的酰化提供了有效的ACC抑制剂。

相似文献

1
Synthesis of 7-oxo-dihydrospiro[indazole-5,4'-piperidine] acetyl-CoA carboxylase inhibitors.7-氧代-二氢螺[吲唑-5,4'-哌啶]乙酰辅酶A羧化酶抑制剂的合成
J Org Chem. 2012 Feb 3;77(3):1497-506. doi: 10.1021/jo202377g. Epub 2012 Jan 25.
2
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors.螺哌啶内酯乙酰辅酶 A 羧化酶抑制剂的合成。
J Org Chem. 2012 Nov 16;77(22):10050-7. doi: 10.1021/jo3014808. Epub 2012 Nov 5.
3
Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.设计并合成二取代(4-哌啶基)哌嗪衍生物作为有效的乙酰辅酶 A 羧化酶抑制剂。
Bioorg Med Chem Lett. 2010 Jul 1;20(13):3965-8. doi: 10.1016/j.bmcl.2010.04.134. Epub 2010 May 4.
4
(4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.(4-哌啶基)哌嗪:乙酰辅酶 A 羧化酶抑制剂的新平台。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6645-8. doi: 10.1016/j.bmcl.2009.10.012. Epub 2009 Oct 8.
5
Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.新型螺哌啶类乙酰辅酶 A 羧化酶抑制剂的设计、合成及构效关系研究。
Bioorg Med Chem Lett. 2012 Jun 1;22(11):3643-7. doi: 10.1016/j.bmcl.2012.04.047. Epub 2012 Apr 19.
6
Discovery of novel (4-piperidinyl)-piperazines as potent and orally active acetyl-CoA carboxylase 1/2 non-selective inhibitors: F-Boc and triF-Boc groups are acid-stable bioisosteres for the Boc group.发现新型(4-哌啶基)哌嗪类化合物作为有效的、口服活性的乙酰辅酶 A 羧化酶 1/2 非选择性抑制剂:F-Boc 和三 F-Boc 基团是 Boc 基团的酸稳定生物等排体。
Bioorg Med Chem. 2011 Mar 1;19(5):1580-93. doi: 10.1016/j.bmc.2011.01.041. Epub 2011 Jan 27.
7
Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase.最大限度提高脂溶性效率:在乙酰辅酶 A 羧化酶抑制剂设计中使用自由威尔逊分析。
J Med Chem. 2012 Jan 26;55(2):935-42. doi: 10.1021/jm201503u. Epub 2012 Jan 11.
8
Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.具有对称结构的螺吡咯烷二酮类化合物作为乙酰辅酶 A 羧化酶抑制剂。
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4769-72. doi: 10.1016/j.bmcl.2012.05.062. Epub 2012 May 19.
9
Regioselective construction and screening of 1,3-disubstituted tetrahydroindazolones in enantiomerically pure pairs.在对映纯对中立体选择性构建和筛选 1,3-二取代四氢吲哚酮。
ACS Comb Sci. 2012 Jan 9;14(1):66-74. doi: 10.1021/co200150d. Epub 2011 Dec 1.
10
Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.强效联苯和 3-苯基吡啶基乙酰辅酶 A 羧化酶抑制剂。
Bioorg Med Chem Lett. 2009 Oct 15;19(20):5872-6. doi: 10.1016/j.bmcl.2009.08.077. Epub 2009 Aug 26.

引用本文的文献

1
Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetes.在发现用于治疗糖尿病的临床乙酰辅酶A羧化酶抑制剂过程中降低代谢性酮还原速率。
J Med Chem. 2014 Dec 26;57(24):10512-26. doi: 10.1021/jm5016022. Epub 2014 Dec 11.
2
Structure and function of biotin-dependent carboxylases.生物素依赖羧化酶的结构与功能。
Cell Mol Life Sci. 2013 Mar;70(5):863-91. doi: 10.1007/s00018-012-1096-0. Epub 2012 Aug 7.